cimoxatone has been researched along with methoxyhydroxyphenylglycol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garrick, NA; Linnoila, M; Murphy, DL; Seppala, T | 1 |
| Deniker, P; Lesage, A; Lôo, H; Olié, JP; Poirier, MF; Rovei, V; Strolin Benedetti, M | 1 |
| Dordain, G; Dostert, P; Eschalier, A; Lesage, A; Rovei, V; Strolin Benedetti, M; Zarifian, E | 1 |
2 trial(s) available for cimoxatone and methoxyhydroxyphenylglycol
| Article | Year |
|---|---|
[Antidepressive action, pharmacokinetic characteristics and biochemical properties of cimoxatone, a new reversible MAO-A inhibitor].
Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Female; Humans; Kinetics; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Prolactin | 1983 |
Effect of a reversible and selective MAO-A inhibitor (cimoxatone) on diurnal variation in plasma prolactin level in man.
Topics: Adult; Circadian Rhythm; Humans; Hydrocortisone; Kinetics; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Prolactin | 1984 |
1 other study(ies) available for cimoxatone and methoxyhydroxyphenylglycol
| Article | Year |
|---|---|
Rhesus monkey cerebrospinal fluid amine metabolite changes following treatment with the reversible monoamine oxidase type-A inhibitor cimoxatone.
Topics: Animals; Biogenic Amines; Dose-Response Relationship, Drug; Homovanillic Acid; Hydroxyindoleacetic Acid; Macaca mulatta; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones | 1985 |